DeSimone John 4
4 · HERBALIFE LTD. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
DeSimone John
Chief Financial Officer
Transactions
- Award
Stock Appreciation Rights
2024-03-25+1,532,769→ 1,532,769 totalExercise: $9.33Exp: 2034-03-25→ Common Stock (1,532,769 underlying)
Footnotes (1)
- [F1]Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on March 25, 2025, and 50% on March 25, 2026, subject to certain conditions of his service as Chief Financial Officer.